Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 6
991
Views
30
CrossRef citations to date
0
Altmetric
Animal Phermacokinetics and Metabolism

Toxicokinetics of perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) in male and female Hsd:Sprague dawley SD rats following intravenous or gavage administration

, , , , , , & show all
Pages 722-732 | Received 20 Aug 2019, Accepted 19 Oct 2019, Published online: 07 Nov 2019

References

  • Barry V, Winquist A, Steenland K. (2013). Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 121:1313–8.
  • Bischel HN, MacManus-Spencer LA, Luthy RG. (2010). Noncovalent interactions of long-chain perfluoroalkyl acids with serum albumin. Environ Sci Technol 44:5263–9.
  • Buck RC, Franklin J, Berger U, et al. (2011). Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and origins. Integr Environ Assess Manag 7:513–41.
  • Calafat AM, Kuklenyik Z, Caudill SP, et al. (2006). Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol 40:2128–34.
  • Calafat AM, Wong LY, Kuklenyik Z, et al. (2007). Polyfluoroalkyl chemicals in the U.S. population: Data from the national health and nutrition examination survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596–602.
  • Chengelis CP, Kirkpatrick JB, Myers NR, et al. (2009). Comparison of the toxicokinetic behavior of perfluorohexanoic acid (PFHxA) and nonafluorobutane-1-sulfonic acid (PFBS) in cynomolgus monkeys and rats. Reprod Toxicol 27:400–6.
  • DeWitt JC, Peden-Adams MM, Keller JM, Germolec DR. (2012). Immunotoxicity of Perfluorinated Compounds: Recent Developments. Toxicol Pathol 40:300–11.
  • Fei C, McLaughlin JK, Lipworth L, Olsen J. (2009). Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 24:1200–5.
  • Gabrielsson J, Weiner D. 2000. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. 4th ed. Stockholm (Sweden): Swedish Pharmaceutical Press.
  • Harada K, Inoue K, Morikawa A, et al. (2005). Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 99:253–61.
  • Kataria A, Trachtman H, Malaga-Dieguez L, Trasande L. (2015). Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents. Environ Health 14:89.
  • Kim S-J, Heo S-H, Lee D-S, et al. (2016). Gender differences in pharmacokinetics and tissue distribution of 3 perfluoroalkyl and polyfluoroalkyl substances in rats. Food Chem Toxicol 97:243–55.
  • Kristensen SL, Ramlau-Hansen CH, Ernst E, et al. (2013). Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction. Hum Reprod 28:3337–48.
  • Kudo N, Katakura M, Sato Y, Kawashima Y. (2002). Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem Biol Interact 139:301–16.
  • Kudo N, Kawashima Y. (2003). Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J Toxicol Sci 28:49–57.
  • Kudo N, Suzuki E, Katakura M, et al. (2001). Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem Biol Interact 134:203–16.
  • Lau C, Anitole K, Hodes C, et al. (2007). Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicological Sciences 99:366–94.
  • Lau C, Butenhoff JL, Rogers JM. (2004). The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198:231–41.
  • Mahapatra CT, Damayanti NP, Guffey SC, et al. (2017). Comparative in vitro toxicity assessment of perfluorinated carboxylic acids. J Appl Toxicol 37:699–708.
  • National Toxicology Program. (2019).  Technical report on the toxicity studies of perfluoroalkyl carboxylates (perfluorohexanoic acid, perfluorooctanoic acid, perfluorononanoic acid, and perfluorodecanoic acid) administered by gavage to Sprague Dawley (Hsd:Sprague Dawley SD) rats. Toxicity Report 97. Research Triangle Park (NC): National Toxicology Program. Available at: 10.22427/NTP-TOX-97.
  • Nelson JW, Hatch EE, Webster TF. (2010). Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197–202.
  • Ng CA, Hungerbühler K. (2013). Bioconcentration of perfluorinated alkyl acids: How important is specific binding? Environ Sci Technol 47:7214–23.
  • Nolan LA, Nolan JM, Shofer FS, et al. (2009). The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27:231–8.
  • Nolan LA, Nolan JM, Shofer FS, et al. (2010). Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 29:147–55.
  • Ohmori K, Kudo N, Katayama K, Kawashima Y. (2003). Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184:135–40.
  • Olsen GW, Burris JM, Ehresman DJ, et al. (2007). Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298–305.
  • Russell MH, Nilsson H, Buck RC. (2013). Elimination kinetics of perfluorohexanoic acid in humans and comparison with mouse, rat and monkey. Chemosphere 93:2419–25.
  • Tatum-Gibbs K, Wambaugh JF, Das KP, et al. (2011). Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse. Toxicology 281:48–55.
  • Vanden Heuvel JP, Kuslikis BI, Van Rafelghem MJ, Peterson RE. (1991a). Disposition of perfluorodecanoic acid in male and female rats. Toxicol Appl Pharmacol 107:450–9.
  • Vanden Heuvel JP, Kuslikis BI, Van Rafelghem MJ, Peterson RE. (1991b). Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol 6:83–92.
  • Wang Z, Cousins IT, Scheringer M, Hungerbühler K. (2013). Fluorinated alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential precursors. Environ Int 60:242–8.
  • Ward KW, Azzarano LM, Evans CA, et al. (2004). Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations. Xenobiotica 34:353–66.
  • Weaver YM, Ehresman DJ, Butenhoff JL, Hagenbuch B. (2010). Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths. Toxicol Sci 113:305–14.
  • Ylinen M, Auriola S. (1990). Tissue Distribution and Elimination of Perfluorodecanoic Acid in the Rat after Single Intraperitoneal Administration. Pharmacol Toxicol 66:45–8.
  • Zhang Y, Beesoon S, Zhu L, Martin JW. (2013). Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environ Sci Technol 47:10619–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.